Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Reactivation of Human Herpes Virus-6 after Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association with Severity of Acute Graft-Versus-Host Disease.

Verhoeven DH, Claas EC, Jol-van der Zijde CM, Thijssen JC, Lankester AC, Bredius RG, Putter H, Kroes AC, Egeler RM, Schilham MW, van Tol MJ.

Pediatr Infect Dis J. 2015 Jun 30. [Epub ahead of print]

PMID:
26132825
2.

Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.

van Schaarenburg RA, Schejbel L, Truedsson L, Topaloglu R, Al-Mayouf SM, Riordan A, Simon A, Kallel-Sellami M, Arkwright PD, Åhlin A, Hagelberg S, Nielsen S, Shayesteh A, Morales A, Tam S, Genel F, Berg S, Ketel AG, Merlijn van den Berg J, Kuijpers TW, Olsson RF, Huizinga TW, Lankester AC, Trouw LA.

J Autoimmun. 2015 Jun 25. pii: S0896-8411(15)00084-0. doi: 10.1016/j.jaut.2015.06.002. [Epub ahead of print]

PMID:
26119135
3.

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture.

Buddingh EP, Ruslan SE, Reijnders CM, Szuhai K, Kuijjer ML, Roelofs H, Hogendoorn PC, Egeler RM, Cleton-Jansen AM, Lankester AC.

Clin Sarcoma Res. 2015 Jun 23;5:16. doi: 10.1186/s13569-015-0031-1. eCollection 2015.

4.

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Peffault de Latour R, Peters C, Gibson B, Strahm B, Lankester A, de Heredia CD, Longoni D, Fioredda F, Locatelli F, Yaniv I, Wachowiak J, Donadieu J, Lawitschka A, Bierings M, Wlodarski M, Corbacioglu S, Bonanomi S, Samarasinghe S, Leblanc T, Dufour C, Dalle JH.

Bone Marrow Transplant. 2015 Jun 8. doi: 10.1038/bmt.2015.117. [Epub ahead of print]

PMID:
26052913
5.

Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis.

Xiao Y, Zijl S, Wang L, de Groot DC, van Tol MJ, Lankester AC, Borst J.

Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012. Epub 2015 May 21.

6.

The number of T cell allo-epitopes associates with CD4+ and CD8+ T-cell infiltration in pediatric cutaneous GVHD.

Thus KA, van Halteren AG, de Hond TA, van Dijk MR, Kloos RQ, Lankester AC, Bierings MB, Spierings E.

Cell Immunol. 2015 Jun;295(2):112-7. doi: 10.1016/j.cellimm.2015.03.001. Epub 2015 Mar 16.

PMID:
25880102
7.

Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.

Boerman GH, van Ostaijen-ten Dam MM, Kraal KC, Santos SJ, Ball LM, Lankester AC, Schilham MW, Egeler RM, van Tol MJ.

Cancer Immunol Immunother. 2015 May;64(5):573-83. doi: 10.1007/s00262-015-1657-9. Epub 2015 Feb 18.

8.

Expression of the immune regulation antigen CD70 in osteosarcoma.

Pahl JH, Santos SJ, Kuijjer ML, Boerman GH, Sand LG, Szuhai K, Cleton-Jansen A, Egeler RM, Boveé JV, Schilham MW, Lankester AC.

Cancer Cell Int. 2015 Mar 18;15:31. doi: 10.1186/s12935-015-0181-5. eCollection 2015.

9.

CD56(dim)CD16⁻ NK cell phenotype can be induced by cryopreservation.

Lugthart G, van Ostaijen-ten Dam MM, van Tol MJ, Lankester AC, Schilham MW.

Blood. 2015 Mar 12;125(11):1842-3. doi: 10.1182/blood-2014-11-610311. No abstract available.

PMID:
25766566
10.

Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.

Kosmoliaptsis V, Jöris MM, Mallon DH, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Bradley JA, Oudshoorn M, van Rood JJ, Taylor CJ, Claas FH.

Bone Marrow Transplant. 2015 Apr;50(4):540-4. doi: 10.1038/bmt.2014.305. Epub 2015 Jan 26.

PMID:
25621806
11.

Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.

Willemsen L, Jol-van der Zijde CM, Admiraal R, Putter H, Jansen-Hoogendijk AM, Ostaijen-Ten Dam MM, Wijnen JT, van Kesteren C, Waaijer JL, Lankester AC, Bredius RG, van Tol MJ.

Biol Blood Marrow Transplant. 2015 Mar;21(3):473-82. doi: 10.1016/j.bbmt.2014.11.674. Epub 2014 Dec 5.

PMID:
25485863
12.

The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.

Lugthart G, Oomen MA, Jol-van der Zijde CM, Ball LM, Bresters D, Kollen WJ, Smiers FJ, Vermont CL, Bredius RG, Schilham MW, van Tol MJ, Lankester AC.

Biol Blood Marrow Transplant. 2015 Feb;21(2):293-9. doi: 10.1016/j.bbmt.2014.10.012. Epub 2014 Oct 16.

PMID:
25464118
13.

Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.

van Schaarenburg RA, Daha NA, Schonkeren JJ, Nivine Levarht EW, van Gijlswijk-Janssen DJ, Kurreeman FA, Roos A, van Kooten C, Koelman CA, Ernst-Kruis MR, Toes RE, Huizinga TW, Lankester AC, Trouw LA.

Immunobiology. 2015 Mar;220(3):422-7. doi: 10.1016/j.imbio.2014.10.005. Epub 2014 Oct 18.

PMID:
25454803
14.

Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia.

Boztug H, Zecca M, Sykora KW, Veys P, Lankester A, Slatter M, Skinner R, Wachowiak J, Pötschger U, Glogova E, Peters C; EBMT paediatric diseases working party.

Ann Hematol. 2015 Feb;94(2):297-306. doi: 10.1007/s00277-014-2196-8. Epub 2014 Sep 19.

PMID:
25231927
15.

Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation.

Vossen JM, Guiot HF, Lankester AC, Vossen AC, Bredius RG, Wolterbeek R, Bakker HD, Heidt PJ.

PLoS One. 2014 Sep 2;9(9):e105706. doi: 10.1371/journal.pone.0105706. eCollection 2014.

16.

Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.

Pike-Overzet K, Baum C, Bredius RG, Cavazzana M, Driessen GJ, Fibbe WE, Gaspar HB, Hoeben RC, Lagresle-Peyrou C, Lankester A, Meij P, Schambach A, Thrasher A, Van Dongen JJ, Zwaginga JJ, Staal FJ.

J Allergy Clin Immunol. 2014 Jul;134(1):242-3. doi: 10.1016/j.jaci.2014.04.033. Epub 2014 Jun 26. No abstract available.

PMID:
25117803
17.

Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.

Dvorak CC, Hassan A, Slatter MA, Hönig M, Lankester AC, Buckley RH, Pulsipher MA, Davis JH, Güngör T, Gabriel M, Bleesing JH, Bunin N, Sedlacek P, Connelly JA, Crawford DF, Notarangelo LD, Pai SY, Hassid J, Veys P, Gennery AR, Cowan MJ.

J Allergy Clin Immunol. 2014 Oct;134(4):935-943.e15. doi: 10.1016/j.jaci.2014.06.021. Epub 2014 Aug 7.

PMID:
25109802
18.

Outcome of invasive mechanical ventilation after pediatric allogeneic hematopoietic SCT: results from a prospective, multicenter registry.

van Gestel JP, Bierings MB, Dauger S, Dalle JH, Pavlíček P, Sedláček P, Monteiro LM, Lankester A, Bollen CW.

Bone Marrow Transplant. 2014 Oct;49(10):1287-92. doi: 10.1038/bmt.2014.147. Epub 2014 Jul 28.

PMID:
25068426
19.

Will post-transplantation cell therapies for pediatric patients become standard of care?

Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, Pulsipher MA, Nierkens S, Schultz K, Handgretinger R, Grupp SA, Boelens JJ, Bollard CM; Westhafen Intercontinental Group.

Biol Blood Marrow Transplant. 2015 Mar;21(3):402-11. doi: 10.1016/j.bbmt.2014.07.018. Epub 2014 Jul 23. Review.

PMID:
25064748
20.

Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease.

Calkoen FG, Vervat C, van Halteren AG, Welters MJ, Veltrop-Duits LA, Lankester AC, Egeler RM, Ball LM, van Tol MJ.

Stem Cells Transl Med. 2014 Aug;3(8):899-910. doi: 10.5966/sctm.2013-0191. Epub 2014 Jun 5.

PMID:
24904175
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk